| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Evolv Technologies Holdings, Inc.
13G/A
EVLV · 30049H102
|
1.4% |
9/22/2025
Event 9/18/2025
|
||||
| Gates Frontier, LLC | 1.4% | |||||
| William H. Gates III | 1.4% | |||||
|
Lyell Immunopharma, Inc.
13G
LYEL · 55083R203
|
5.6% |
8/1/2025
Event 7/25/2025
|
||||
| Gates Frontier, LLC | 5.6% | |||||
| William H. Gates III | 5.6% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.